Memories, like a jigsaw puzzle, are scattered across our minds. Each piece is carefully placed to create an intricate web of memories that make up who we are and how we interact with the world around us.
Exploring the Connection Between Alzheimer’s and Dementia Read More »
Exercise and physical therapy play an important role in managing Multiple Sclerosis (MS). Not only can it improve quality of life, but it also has been found to reduce fatigue and improve mobility.
Community Resources For Alzheimer’s Patients And Their Loved Ones Read More »
Alzheimer’s disease is a progressive and degenerative disorder that affects an individual’s brain and cognitive functions. It is a type of dementia, a general term for the deterioration of cognitive functions that affects memory, thinking, behavior, and the ability to perform everyday activities.
Maximizing Quality of Life for Alzheimer’s Patients Read More »
Multiple Sclerosis is a neurological condition that affects the brain, spinal cord, and optic nerves. While there is no cure for the condition, treatments can help reduce the severity of symptoms and manage the disease.
Living with Multiple Sclerosis: Coping Strategies and Support Resources Read More »
Exercise and physical therapy play an important role in managing Multiple Sclerosis (MS). Not only can it improve quality of life, but it also has been found to reduce fatigue and improve mobility.
Exercise and Physical Therapy for Multiple Sclerosis Read More »
Alzheimer’s disease is a progressive and degenerative disorder that affects an individual’s brain and cognitive functions. It is a type of dementia, a general term for the deterioration of cognitive functions that affects memory, thinking, behavior, and the ability to perform everyday activities.
Understanding the Symptoms of Alzheimer’s Disease Read More »
Dr. Eric Folkens, MD, is a highly qualified family medicine doctor and Pharmaceutical Medical Researcher based in Bradenton, Florida. He has over 22 years of experience in the medical field and is licensed to practice medicine in the state of Florida. Throughout his career, Dr. Folkens has held positions in group practices and worked as
Dr. Eric Folkens,MD. Read More »
Accelerated Approval is based on Phase 2 data showing a reduction in amyloid-beta plaques in early AD patients treated with LEQEMBI™ Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials TOKYO and CAMBRIDGE, Mass., Jan. 6,
Multiple Sclerosis is a long-term illness where the body’s immune system attacks and damages the protective covering, called myelin, around the nerves in the central nervous system. People with relapsing MS will have repeated attacks, known as relapses, and we’re finding new ways to stop them. People with MS can experience a variety of symptoms,
WE’RE FINDING NEW WAYS TO TREAT MULTIPLE SCLEROSIS Read More »
Alzheimer’s disease is the most frequent cause of dementia in Western societies. In the US, approximately 6.5 million people are affected, and the prevalence worldwide is estimated to be as high as 50 million. As the population continues to age, the number of individuals at risk will also increase. Alzheimer’s disease is the leading cause
THERE IS HOPE IN TREATING ALZHEIMER’S DISEASE AND ONE DAY, FINDING A CURE Read More »
Copyright © 2024 Bradenton Research Center | Website Designed by Rohring Results
